Lupin shares jump 5% after strong Q1 results. Should you accumulate more?
[hfe_template id='11223']
[ad_1]
Lupin shares surged 5% to Rs 1,940 in Thursday’s trade after the pharmaceutical giant reported a strong set of Q1 FY26 results, with consolidated net profit rising 52% year-on-year to Rs 1,221 crore, compared to Rs 805 crore in the same quarter last year. The impressive performance was driven by robust growth in both the US and Indian markets. Revenue for the quarter stood at Rs 6,164 crore, up from Rs 5,514 crore a year ago. “We continue to build strong business momentum, anchored by a robust product portfolio, improved efficiencies, and effective use of assets and investments,” said Nilesh Gupta, Managing Director, Lupin. “As we begin the year, our sharpened focus on compliance, innovation, and technology positions us to further unlock sustainable growth,” he added. The company reported US sales of Rs 2,404 crore in the June quarter, registering a 24% growth compared to Rs 1,934 crore in the year-ago period. Live Events Should you buy, ...